Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Fehrman

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Transplantation Proceedings|February 1, 1993
Characteristics of long-term survivors (> 20 years) after kidney transplantationI Fehrman-Ekholm, H Gäbel, N H Persson, et al.
Scandinavian Journal of Urology and Nephrology. Supplementum|January 1, 1980
Cadaveric renal graft survival: the bearing of the number of blood transfusions and of dialysis treatmentI Fehrman, J Fehrman, G Lundgren, et al.
Journal of Internal Medicine|February 1, 1996
Increased prevalence of atherosclerotic wall changes in patients with hyperlipidaemia after renal transplantationT Jogestrand, I Fehrman-Ekholm, B Angelin, et al.
Transplantation Proceedings|March 1, 1981
Is cell-mediated immunity in the uremic patient affected by blood transfusion?I Fehrman, O Ringdén, E Möller, et al.
Transplantation Proceedings|March 1, 1979
Pretransplant dialysis and blood transfusion--correlation with cadaveric kidney graft survivalI Fehrman, C G Groth, G Lundgren, et al.
Transplantation|August 15, 2001
No evidence of accelerated loss of kidney function in living kidney donors: results from a cross-sectional follow-upI Fehrman-Ekholm, F Dunér, B Brink, et al.
Transplantation Proceedings|November 22, 2005
ABO-incompatible kidney transplantation and rituximabG Tydén, G Kumlien, H Genberg, et al.
Transplantation Proceedings|February 1, 1987
Omission of donor-recipient crossmatching to minimize cold ischemia time in cadaveric renal transplantationI Fehrman, C G Groth, G Lundgren, et al.
Transplantation|November 5, 1997
Kidney donors live longerI Fehrman-Ekholm, C G Elinder, M Stenbeck, et al.
Transplantation Proceedings|August 1, 1988
Liver transplant aspiration cytology is useful for monitoring steroid treatment of rejectionC L Greene, I Fehrman, G W Tillery, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Transplantation Proceedings|February 1, 1993
Characteristics of long-term survivors (> 20 years) after kidney transplantationI Fehrman-Ekholm, H Gäbel, N H Persson, et al.
Scandinavian Journal of Urology and Nephrology. Supplementum|January 1, 1980
Cadaveric renal graft survival: the bearing of the number of blood transfusions and of dialysis treatmentI Fehrman, J Fehrman, G Lundgren, et al.
Journal of Internal Medicine|February 1, 1996
Increased prevalence of atherosclerotic wall changes in patients with hyperlipidaemia after renal transplantationT Jogestrand, I Fehrman-Ekholm, B Angelin, et al.
Transplantation Proceedings|March 1, 1981
Is cell-mediated immunity in the uremic patient affected by blood transfusion?I Fehrman, O Ringdén, E Möller, et al.
Transplantation Proceedings|March 1, 1979
Pretransplant dialysis and blood transfusion--correlation with cadaveric kidney graft survivalI Fehrman, C G Groth, G Lundgren, et al.
Transplantation|August 15, 2001
No evidence of accelerated loss of kidney function in living kidney donors: results from a cross-sectional follow-upI Fehrman-Ekholm, F Dunér, B Brink, et al.
Transplantation Proceedings|November 22, 2005
ABO-incompatible kidney transplantation and rituximabG Tydén, G Kumlien, H Genberg, et al.
Transplantation Proceedings|February 1, 1987
Omission of donor-recipient crossmatching to minimize cold ischemia time in cadaveric renal transplantationI Fehrman, C G Groth, G Lundgren, et al.
Transplantation|November 5, 1997
Kidney donors live longerI Fehrman-Ekholm, C G Elinder, M Stenbeck, et al.
Transplantation Proceedings|August 1, 1988
Liver transplant aspiration cytology is useful for monitoring steroid treatment of rejectionC L Greene, I Fehrman, G W Tillery, et al.
Pageof 6